Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

.

Authors:
Bruce S Wilson Julian Peiser-Oliver Alexander Gillis Sally Evans Claudia Alamein Shannon N Mostyn Susan Shimmon Tristan Rawling MacDonald J Christie Robert J Vandenberg Sarasa A Mohammadi

J Pharmacol Exp Ther 2022 Jul 2. Epub 2022 Jul 2.

Discipline of Pharmacology, Sydney Pharmacy School, The University of Sydney, Australia

Aberrations in spinal glycinergic signalling are a feature of pain chronification. Normalising these changes by inhibiting glycine transporter-2 (GlyT2) is a promising treatment strategy. However, existing GlyT2 inhibitors e.g. ORG25543 are limited by narrow therapeutic windows and severe dose-limiting side effects such as convulsions, and are therefore poor candidates for clinical development. Here, intraperitoneally administered oleoyl--lysine, a lipid-based GlyT2 inhibitor, was characterised in mouse models of acute (hotplate), inflammatory (CFA) and chronic neuropathic (CCI) pain. Side effects were also assessed on a numerical rating score, convulsions score, for motor incoordination (rotarod) and for respiratory depression (whole body plethysmography). Oleoyl--lysine produced near complete anti-allodynia for chronic neuropathic pain but no anti-allodynia/analgesia in inflammatory or acute pain. No side effects were seen at the peak analgesic dose, 30 mg/kg. Mild side effects were observed at the highest dose, 100 mg/kg, on the numerical rating score, but no convulsions. These results contrasted markedly with ORG25543, which reached less than 50% reduction in allodynia score only at the lethal/near-lethal dose of 50 mg/kg. At this dose, ORG25543 caused maximal side effects on the numerical rating score and severe convulsions. Oleoyl--lysine (30 mg/kg) did not cause any respiratory depression, a problematic side effect of opiates. These results show the safe and effective reversal of neuropathic pain in mice by oleoyl--lysine and provide evidence for a distinct role of glycine in chronic pain over acute or short-term pain conditions. Partially inhibiting GlyT2 can alleviate chronic pain by restoring lost glycinergic function. Novel lipid-based GlyT2 inhibitor, ol--lys, is safe and effective in alleviating neuropathic pain, but not inflammatory or acute pain. Clinical application of GlyT2 inhibitors may be better suited to chronic neuropathic pain over other pain aetiologies.

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.122.001265DOI Listing
July 2022

Publication Analysis

Top Keywords

side effects
20
neuropathic pain
16
numerical rating
12
chronic neuropathic
12
rating score
12
pain
12
dose mg/kg
8
pain side
8
chronic pain
8
lipid-based glyt2
8
safe effective
8
acute pain
8
score convulsions
8
glyt2 inhibitor
8
glyt2 inhibitors
8
respiratory depression
8
inflammatory acute
8
glyt2
6
side
6
chronic
5

Keyword Occurance

Similar Publications

Haemophagocytic lymphohistiocytosis as a complication of combination anti-PD-1 and anti-CTLA-4 checkpoint inhibitor immunotherapy for metastatic melanoma, and the outcome of rechallenge with single-agent anti-PD-1 immunotherapy.

Authors:
Zachary Holmes Ashling Courtney Alison Hiong

BMJ Case Rep 2022 Aug 10;15(8). Epub 2022 Aug 10.

Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

A woman with metastatic melanoma was treated with immunotherapy induction with ipilimumab and nivolumab and radiotherapy to liver metastases. The patient deteriorated shortly thereafter, becoming febrile and hypotensive and requiring admission to the intensie care unit (ICU) for inotrope support. Failure to respond to antibiotics and a negative septic screen prompted further investigation, which ultimately led to a diagnosis of haemophagocytic lymphohistiocytosis (HLH). Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Covid-19 vaccination in pregnancy.

Authors:
Martina L Badell Carolynn M Dude Sonja A Rasmussen Denise J Jamieson

BMJ 2022 Aug 10;378:e069741. Epub 2022 Aug 10.

Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA. USA.

Pregnancy is an independent risk factor for severe covid-19. Vaccination is the best way to reduce the risk for SARS-CoV-2 infection and limit its morbidity and mortality. The current recommendations from the World Health Organization, Centers for Disease Control and Prevention, and professional organizations are for pregnant, postpartum, and lactating women to receive covid-19 vaccination. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Preconception and periconception interventions to prevent low birth weight, small for gestational age and preterm birth: a systematic review and meta-analysis.

Authors:
Uttara Partap Ranadip Chowdhury Sunita Taneja Nita Bhandari Ayesha De Costa Rajiv Bahl Wafaie Fawzi

BMJ Glob Health 2022 Aug;7(8)

Department of Global Health and Population, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA.

Background: Low birth weight (LBW), including preterm birth (PTB) and small for gestational age (SGA), contributes a significant global health burden. We aimed to summarise current evidence on the effect of preconception and periconception interventions on LBW, SGA and PTB.

Methods: In this systematic review and meta-analysis, we searched PubMed, Embase, Cochrane Library and WHO Global Index Medicus for randomised controlled trials and quasi-experimental studies published by 28 November 2020, which assessed interventions delivered in preconception and periconception or preconception and pregnancy. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Therapeutic effects of antidepressants for global improvement and subdomain symptoms of autism spectrum disorder: a systematic review and meta-analysis.

Authors:
Shun-Chin Liang Cheuk-Kwan Sun Hsin-Yi Fan Weilun Chung Ruu-Fen Tzang Kuo-Chuan Hung Hsien-Jane Chiu Yu-Shian Cheng Pin-Yang Yeh

J Psychiatry Neurosci 2022 Jul-Aug;47(4):E299-E310. Epub 2022 Aug 10.

From the Department of Management Centre, Jianan Psychiatric Centre, Ministry Of Health and Welfare, Tainan, Taiwan (Liang); the Centre for General Education, University of Kun Shan, Tainan, Taiwan (Liang); the Department of Emergency Medicine, E-Da Hospital, Kaohsiung, Taiwan (Sun); the School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung, Taiwan (Sun); the Department of Psychiatry, Tsyr-Huey Mental Hospital, Kaohsiung Jen-Ai's Home, Taiwan (Fan, Chung, Cheng); the Department of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwan (Tzang); the Department of Anesthesiology, Chi Mei Medical Centre, Tainan, Taiwan (Hung); the Taoyuan Psychiatric Centre, Ministry of Health and Welfare, Taoyuan City, Taiwan (Chiu); the Institute of Hospital and Health Care Administration, National Yang-Ming University, Taipei City, Taiwan (Chiu); the Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung City, Taiwan (Cheng); the Department of Psychology, College of Medical and Health Science, Asia University, Taichung, Taiwan (Yeh); Clinical Psychology Center, Asia University Hospital, Taichung, Taiwan (Yeh)

Background: No established pharmacological treatment is available for the core symptoms of autism spectrum disorder (ASD). This study aimed at investigating the efficacy of antidepressants for the core and associated symptoms of ASD.

Methods: We searched PubMed, Embase, ClinicalKey, Cochrane CENTRAL, ScienceDirect, Web of Science and ClinicalTrials. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Fractional Photothermolysis for Treatment of a Residual Discoid Lupus Erythematosus Lesion: A Case Report.

Authors:
David Alvarez Martinez Emmanuel Laffitte Garuna Kositratna Hans-Joachim Laubach

Ann Dermatol 2022 Aug;34(4):301-304

Division of Dermatology and Venereology, University Hospital of Geneva, Geneva, Switzerland.

Cutaneous discoid lupus erythematosus (CDLE) is a chronic inflammatory skin disease often resulting in permanent scarring of the affected area. Fractional photothermolysis (FP) is a well-known inducer of tissue regeneration by wounding the skin in a fractional pattern, hence inducing a well defined, wound healing response. It has been used clinically to treat atrophic as well as hypertrophic scars and also fibrotic diseases like morphea since more than a decade. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap